Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial
about
Nerve growth factor: role in growth, differentiation and controlling cancer cell developmentImmunomodulation on the ocular surface: a reviewHuman Serum Eye Drops in Eye Alterations: An Insight and a Critical AnalysisNerve Growth Factor: A Focus on Neuroscience and TherapyDiagnosis and management of neurotrophic keratitis.Understanding the Pathogenesis of Neurotrophic Keratitis: The Role of Corneal Nerves.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.NGF in Early Embryogenesis, Differentiation, and Pathology in the Nervous and Immune Systems.Probing the functional impact of sub-retinal prosthesis.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Ocular Nerve Growth Factor Administration Modulates Brain-derived Neurotrophic Factor Signaling in Prefrontal Cortex of Healthy and Diabetic Rats.Neurotrophic factors and corneal nerve regeneration.Rare Diseases of the Anterior Segment of the Eye: Update on Diagnosis and ManagementRecombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis Pigmentosa.Neurotrophic keratitis: current challenges and future prospects.
P2860
Q26738684-74B29DD6-57E5-47EA-B737-AEE1396A31ACQ26740643-52EA954D-F6AC-41D5-B1CA-675898DAAC3FQ26778628-46BC400A-51F2-4282-9D57-03F79C60AC54Q26786398-67C450F6-23BF-47FA-B8C4-6E340F5AC58EQ27026580-8D12F338-1B9C-427C-8200-16BD16D3C01BQ34678976-250B9FF0-7ADB-4D80-B2DF-1CD0AE86FC80Q35234189-F45A6F41-10EF-44E3-88B2-4D4CF8B8C19FQ35875769-185AD0B7-B890-430F-96E6-E39EB65905DCQ37198018-6B92FB1B-3F94-4B75-9593-3CEE1923BA2EQ38584194-58AE14AC-DA4B-46DA-9BB7-D5C68AF1B650Q39043559-B94C09CC-092F-48F5-925D-F5C016764018Q41667403-A92763A9-8C6A-4248-9D96-84DA42BA40B3Q41969661-31C55F4C-9820-4A06-B44E-D95A2DED7A8CQ48250988-1479FD15-B4A2-4BDC-8076-B3EA868826DBQ55664586-3E3B7300-4E9A-4687-A9B8-A4EA4EAAD0EC
P2860
Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@ast
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@en
type
label
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@ast
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@en
prefLabel
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@ast
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@en
P2093
P2860
P1433
P1476
Safety and pharmacokinetics of ...... ked, randomized clinical trial
@en
P2093
Flavio Mantelli
Franca Cattani
Francesco Sinigaglia
Gaetano D'Anniballe
Maria Irene Antonangeli
Mauro P Ferrari
Pier Adelchi Ruffini
P2860
P2888
P304
P356
10.1007/S40259-013-0079-5
P577
2014-06-01T00:00:00Z